Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ute Hegenbart

Showing results (21-30 of 237) with videos related to

Pageof 24
Sort By:
Haematologica|June 3, 2008
Bone involvement in patients with systemic AL amyloidosis mimics lytic myeloma bone diseaseStefan O Schonland, Jochen Hansmann, Gunnhild Mechtersheimer, et al.
Virchows Archiv : an International Journal of Pathology|May 27, 2008
Three German fibrinogen Aalpha-chain amyloidosis patients with the p.Glu526Val mutationMagdalena Eriksson, Stefan Schönland, Raoul Bergner, et al.
Biomolecular NMR Assignments|September 18, 2020
Solid state NMR assignments of a human λ-III immunoglobulin light chain amyloid fibrilTejaswini Pradhan, Karthikeyan Annamalai, Riddhiman Sarkar, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 11, 2019
New sequence variants in patients affected by amyloidosis show transthyretin instability by isoelectric focusingKatrin Hinderhofer, Christian Obermaier, Ute Hegenbart, et al.
Leukemia & Lymphoma|December 29, 2004
Remission induction using alemtuzumab can permit chemotherapy-refractory chronic lymphocytic leukemia (CLL) patients to undergo allogeneic stem cell transplantationWolfgang Knauf, Kathrin Rieger, Wolfgang Blau, et al.
Thescientificworldjournal|June 6, 2012
CD4+CD25highCD127low regulatory T cells in peripheral blood are not an independent factor for chronic graft-versus-host disease after allogeneic stem cell transplantationJolanta B Perz, Selma Gürel, Stefan O Schonland, et al.
Plos One|February 25, 2022
Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvementNatalie Berghaus, Sarah Schreiner, Martin Granzow, et al.
Journal of Neurochemistry|November 6, 2020
Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosisMaike F Dohrn, Sandra Ihne, Ute Hegenbart, et al.
The Journal of Biological Chemistry|October 23, 2020
Seeded fibrils of the germline variant of human λ-III immunoglobulin light chain FOR005 have a similar core as patient fibrils with reduced stabilityTejaswini Pradhan, Karthikeyan Annamalai, Riddhiman Sarkar, et al.
Hematological Oncology|July 8, 2017
Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practiceMarc-Andrea Baertsch, Jens Hillengass, Joanna Blocka, et al.
Pageof 24

Showing results (21-30 of 237) with videos related to

Sort By:
Pageof 24
Haematologica|June 3, 2008
Bone involvement in patients with systemic AL amyloidosis mimics lytic myeloma bone diseaseStefan O Schonland, Jochen Hansmann, Gunnhild Mechtersheimer, et al.
Virchows Archiv : an International Journal of Pathology|May 27, 2008
Three German fibrinogen Aalpha-chain amyloidosis patients with the p.Glu526Val mutationMagdalena Eriksson, Stefan Schönland, Raoul Bergner, et al.
Biomolecular NMR Assignments|September 18, 2020
Solid state NMR assignments of a human λ-III immunoglobulin light chain amyloid fibrilTejaswini Pradhan, Karthikeyan Annamalai, Riddhiman Sarkar, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 11, 2019
New sequence variants in patients affected by amyloidosis show transthyretin instability by isoelectric focusingKatrin Hinderhofer, Christian Obermaier, Ute Hegenbart, et al.
Leukemia & Lymphoma|December 29, 2004
Remission induction using alemtuzumab can permit chemotherapy-refractory chronic lymphocytic leukemia (CLL) patients to undergo allogeneic stem cell transplantationWolfgang Knauf, Kathrin Rieger, Wolfgang Blau, et al.
Thescientificworldjournal|June 6, 2012
CD4+CD25highCD127low regulatory T cells in peripheral blood are not an independent factor for chronic graft-versus-host disease after allogeneic stem cell transplantationJolanta B Perz, Selma Gürel, Stefan O Schonland, et al.
Plos One|February 25, 2022
Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvementNatalie Berghaus, Sarah Schreiner, Martin Granzow, et al.
Journal of Neurochemistry|November 6, 2020
Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosisMaike F Dohrn, Sandra Ihne, Ute Hegenbart, et al.
The Journal of Biological Chemistry|October 23, 2020
Seeded fibrils of the germline variant of human λ-III immunoglobulin light chain FOR005 have a similar core as patient fibrils with reduced stabilityTejaswini Pradhan, Karthikeyan Annamalai, Riddhiman Sarkar, et al.
Hematological Oncology|July 8, 2017
Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practiceMarc-Andrea Baertsch, Jens Hillengass, Joanna Blocka, et al.
Pageof 24